Anti-Müllerian hormone: a marker for ovarian function in systemic lupus erythematosus patients treated with cyclophosphamide

Joint Bone Spine. 2013 Jul;80(4):434-5. doi: 10.1016/j.jbspin.2012.10.016. Epub 2012 Dec 21.
No abstract available

Keywords: Anti-Müllerian hormone; Cyclophosphamide; Premature ovarian failure; Systemic lupus erythematosus.

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Age Factors
  • Anti-Mullerian Hormone / blood*
  • Antirheumatic Agents / therapeutic use*
  • Biomarkers / blood
  • Cyclophosphamide / therapeutic use*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / physiopathology
  • Ovarian Diseases / epidemiology
  • Ovary / physiopathology*
  • Predictive Value of Tests
  • Risk Factors

Substances

  • Antirheumatic Agents
  • Biomarkers
  • Anti-Mullerian Hormone
  • Cyclophosphamide